BRD2 and Infertility: We noted significant differences between GnRH antagonist and long-acting GnRH agonist protocols for female age (p = 0.018), fertilization type (p = 0.007), therapeutic regimen (p < 0.001), BMI (p = 0.008), infertility duration (p = 0.042), basal follicle-stimulating hormone (FSH) (p = 0.002), and basal LH (p < 0.001).